SunTrust analyst Bill Chappell raised his price target on Edgewell Personal Care to $45 and kept his Buy rating after its Q1 earnings beat as well as the announcement that it is walking away from the acquisition of Harry's following the FTC lawsuit to block the merger. The analyst notes that the company's base business still continues to show signs of improvement and he sees the stock's valuation discounting its "expected choppiness". At implied 9-times his expected FY20 EBITDA, Chappell adds that the valuation on Edgewell Personal Care is still near the bottom of its peer range.